Valuation : Gabather AB

Market Cap 18.19M 1.88M 1.62M 1.53M 1.39M 2.6M 179M 2.62M 7M 91.26M 7.05M 6.9M 288M P/E 2024
-1.07x
P/E 2025 -1.13x
Enterprise Value 15.05M 1.55M 1.34M 1.27M 1.15M 2.15M 148M 2.17M 5.79M 75.49M 5.83M 5.71M 239M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
90.95%
Yield 2024 *
-
Yield 2025 -
1 day+1.34%
1 week-2.58%
Current month-16.11%
1 month-10.65%
3 months-27.75%
6 months-51.60%
Current year+10.22%
1 week 0.03
Extreme 0.0274
0.03
1 month 0.03
Extreme 0.0274
0.04
Current year 0.02
Extreme 0.023
0.1
1 year 0.02
Extreme 0.023
0.1
3 years 0.02
Extreme 0.023
4.2
5 years 0.02
Extreme 0.023
6.55
10 years 0.02
Extreme 0.023
61.6
Manager TitleAgeSince
Chief Executive Officer - 01/10/2018
Chief Operating Officer - 01/01/2018
Chief Tech/Sci/R&D Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member - 01/09/2014
Director/Board Member 60 03/11/2014
Chairman - 01/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
+1.34%-2.58%-20.94%-98.71% 1.88M
-2.11%-3.44%+41.04%+98.48% 68.24B
-0.23%-4.45%+30.39%+73.64% 62.23B
+1.91%+2.52%-11.19%+388.58% 27.8B
-1.05%-7.30%+25.00%+12.31% 24.86B
+0.67%-6.34%-6.84%-17.61% 24.22B
+0.43%-3.37%+14.85%-19.29% 19.36B
-3.03%-5.19%+192.88%+340.13% 17.28B
-1.94%-6.36%-7.05%+516.16% 14.46B
-1.76%-4.02%+44.97%+157.57% 14.23B
Average -0.57%-4.19%+30.31%+145.13% 27.27B
Weighted average by Cap. -0.78%-3.80%+32.99%+136.40%

Financials

2024 2025
Net sales - -
Net income -7.75M -800K -689K -653K -592K -1.11M -76.44M -1.12M -2.98M -38.89M -3.01M -2.94M -123M -4.65M -480K -414K -392K -355K -666K -45.87M -669K -1.79M -23.34M -1.8M -1.76M -73.74M
Net Debt -878K -90.61K -78.07K -73.93K -67.01K -126K -8.66M -126K -338K -4.4M -340K -333K -13.92M -3.14M -324K -279K -265K -240K -450K -30.99M -452K -1.21M -15.77M -1.22M -1.19M -49.82M
Logo Gabather AB
Gabather AB is a Sweden-based company engaged pharmaceutical industry. The Company develops drug candidates for the treatment of several diseases originating in the central nervous system (CNS). The Company mainly focuses on anti-psychotics, anti-depressants and anxiolytics, analgesics, as well as conginition-enhancing treatments, including Alzheimer’s disease.
Employees
2
Date Price Change Volume
11/09/26 SEK 0.0302 +1.34% 316,407
10/09/26 SEK 0.0298 -0.67% 1,837,604
09/09/26 SEK 0.0300 +3.45% 733,916
08/09/26 SEK 0.0290 -6.45% 2,831,959
07/09/26 SEK 0.0310 0.00% 873,483
  1. Stock Market
  2. Stocks
  3. GABA Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!